Factors Associated With Success of the Extreme Drug Resistance Assay in Primary Breast Cancer Specimens

By Ellis R.J.  

Breast Cancer Research and Treatment, Vol. 71, Iss. 2, 2002-01 ,pp. : 95-102

Springer Publishing Company

Access to resources Recommend Favorite

Correlation between Extreme Drug Resistance Assay and Response to Primary Paclitaxel and Cisplatin in Patients with Epithelial Ovarian Cancer

By Eltabbakh G.H.   Piver M.S.   Hempling R.E.   Recio F.O.   Lele S.B.   Marchetti D.L.   Baker T.R.   Blumenson L.E.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 392-397

Elsevier

Access to resources Recommend Favorite

Relationship between in vivo drug exposure of the tumor interstitium and inhibition of tumor cell growth in vitro: a study in breast cancer patients

By Müller M.  

Breast Cancer Research and Treatment, Vol. 60, Iss. 3, 2000-04 ,pp. : 211-217

Springer Publishing Company

Access to resources Recommend Favorite

Drug resistance in chemotherapy for breast cancer

By Saeki Toshiaki   Tsuruo Takashi   Sato Wakao   Nishikawsa Kiyoshiro  

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 84-89

Springer Publishing Company

Access to resources Recommend Favorite

Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer

By Nakamura Seigo  

Breast Cancer, Vol. 17, Iss. 3, 2010-07 ,pp. : 199-204

Springer Publishing Company

Access to resources Recommend Favorite